Journal of Thoracic Oncology最新文献

筛选
英文 中文
81P: Tepotinib in patients (pts) with METexon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes 81P:替波替尼治疗METexon 14 (METex14)跳过非小细胞肺癌(NSCLC)的患者:≥3年的随访结果
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI: 10.1016/S1556-0864(25)00276-X
Julien Mazieres , R. Veillon , A. Cortot , R. Ferrara , E. Felip , M. Garassino , X. Le , M. Thomas , H. Sakai , E. Smit , J. Raskin , S. Viteri , J.C-H. Yang , M-J. Ahn , Y-L. Wu , J. Zhao , V. Ghori , R. Bruns , A. Johne , P. Paik
{"title":"81P: Tepotinib in patients (pts) with METexon 14 (METex14) skipping non-small cell lung cancer (NSCLC) from the VISION study: ≥3-year follow-up outcomes","authors":"Julien Mazieres , R. Veillon , A. Cortot , R. Ferrara , E. Felip , M. Garassino , X. Le , M. Thomas , H. Sakai , E. Smit , J. Raskin , S. Viteri , J.C-H. Yang , M-J. Ahn , Y-L. Wu , J. Zhao , V. Ghori , R. Bruns , A. Johne , P. Paik","doi":"10.1016/S1556-0864(25)00276-X","DOIUrl":"10.1016/S1556-0864(25)00276-X","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Pages S59-S60"},"PeriodicalIF":21.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143724696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
82P: A retrospective real-world evidence study of MTAP status and clinical outcomes in patients with advanced non-small cell lung cancer MTAP在晚期非小细胞肺癌患者中的状态和临床结果的回顾性实证研究
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI: 10.1016/S1556-0864(25)00277-1
A. Sacher , M. Clouser , A. Balasubramanian , E.H. Elkhouly , A. Hindoyan , X. Zhang , B.E. Sylvester , J. Hildebrand , P. Martinez , M. Villalona-Calero
{"title":"82P: A retrospective real-world evidence study of MTAP status and clinical outcomes in patients with advanced non-small cell lung cancer","authors":"A. Sacher , M. Clouser , A. Balasubramanian , E.H. Elkhouly , A. Hindoyan , X. Zhang , B.E. Sylvester , J. Hildebrand , P. Martinez , M. Villalona-Calero","doi":"10.1016/S1556-0864(25)00277-1","DOIUrl":"10.1016/S1556-0864(25)00277-1","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Pages S60-S61"},"PeriodicalIF":21.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143724697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
77P: EGFR-mutant advanced NSCLC patients continuously benefit from aumolertinib as post secone-line treatment 77P: egfr突变的晚期NSCLC患者持续受益于奥莫替尼作为二线后治疗
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI: 10.1016/S1556-0864(25)00272-2
Z. Liu, L. Wang, C.G. Pan, Z.T. Liu, Q. Wen, Y. Yuan, W.J. Jin
{"title":"77P: EGFR-mutant advanced NSCLC patients continuously benefit from aumolertinib as post secone-line treatment","authors":"Z. Liu, L. Wang, C.G. Pan, Z.T. Liu, Q. Wen, Y. Yuan, W.J. Jin","doi":"10.1016/S1556-0864(25)00272-2","DOIUrl":"10.1016/S1556-0864(25)00272-2","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Page S57"},"PeriodicalIF":21.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143724815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
27P: Impact of platinum-based chemotherapy (CT) on acquired resistance (AR) to first-line immunecheckpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC): Individual patient data metanalysis 27P:铂基化疗(CT)对非小细胞肺癌(NSCLC)一线免疫检查点抑制剂(ICI)获得性耐药(AR)的影响:个体患者数据荟萃分析
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI: 10.1016/S1556-0864(25)00222-9
S. Oresti , F. Salomone , A. Nuccio , F.R. Ogliari , S.T. Riva , L. Mollica , F.M. Venanzi , M. Ferrara , F. Passaretti , L. Papotto , A. Di Lello , A. Bulotta , B. Ricciuti , R. Califano , M. Di Maio , A. Cortellini , V. Torri , M. Cinquini , G. Viscardi , R. Ferrara
{"title":"27P: Impact of platinum-based chemotherapy (CT) on acquired resistance (AR) to first-line immunecheckpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC): Individual patient data metanalysis","authors":"S. Oresti , F. Salomone , A. Nuccio , F.R. Ogliari , S.T. Riva , L. Mollica , F.M. Venanzi , M. Ferrara , F. Passaretti , L. Papotto , A. Di Lello , A. Bulotta , B. Ricciuti , R. Califano , M. Di Maio , A. Cortellini , V. Torri , M. Cinquini , G. Viscardi , R. Ferrara","doi":"10.1016/S1556-0864(25)00222-9","DOIUrl":"10.1016/S1556-0864(25)00222-9","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Pages S28-S29"},"PeriodicalIF":21.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143725239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
84P: High prevalence of actionable driver alterations in lung cancer patients with germline MUTYH mutations 84P:在种系MUTYH突变的肺癌患者中,可操作的驱动改变的患病率很高
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI: 10.1016/S1556-0864(25)00279-5
Z.L. Arter, F. Luo, C. Park, M. Nagasaka, S-H.I. Ou
{"title":"84P: High prevalence of actionable driver alterations in lung cancer patients with germline MUTYH mutations","authors":"Z.L. Arter, F. Luo, C. Park, M. Nagasaka, S-H.I. Ou","doi":"10.1016/S1556-0864(25)00279-5","DOIUrl":"10.1016/S1556-0864(25)00279-5","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Page S62"},"PeriodicalIF":21.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143725572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
80P: Final overall survival and long-term safety outcomes of savolitinib in patients with locally advanced or metastatic NSCLC harboring METexon 14 (METex14) mutation: An update from a phase IIIb study 80P: savolitinib在携带METexon 14 (METex14)突变的局部晚期或转移性NSCLC患者中的最终总生存期和长期安全性结果:来自IIIb期研究的最新结果
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI: 10.1016/S1556-0864(25)00275-8
Y. Yu , Q. Guo , Y. Zhang , J. Fang , D. Zhong , B. Liu , P. Pan , D. Lv , L. Wu , Y. Zhao , J. Li , Z. Liu , C. Liu , Y. Wang , B. Jin , Q. Song , S. Fan , M. Shi , W. Su , S. Lu
{"title":"80P: Final overall survival and long-term safety outcomes of savolitinib in patients with locally advanced or metastatic NSCLC harboring METexon 14 (METex14) mutation: An update from a phase IIIb study","authors":"Y. Yu , Q. Guo , Y. Zhang , J. Fang , D. Zhong , B. Liu , P. Pan , D. Lv , L. Wu , Y. Zhao , J. Li , Z. Liu , C. Liu , Y. Wang , B. Jin , Q. Song , S. Fan , M. Shi , W. Su , S. Lu","doi":"10.1016/S1556-0864(25)00275-8","DOIUrl":"10.1016/S1556-0864(25)00275-8","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Page S59"},"PeriodicalIF":21.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143725631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
42P: First-line (1L) nivolumab (N) + ipilimumab (I) with 2 cycles of platinum-based chemotherapy (C) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): Interim data from the German non-interventional study (NIS) FINN 42P:在转移性非小细胞肺癌(mNSCLC)患者(pts)中,一线(1L) nivolumab (N) + ipilimumab (I)联合2个周期铂基化疗(C):来自德国非介入性研究(NIS) FINN的中期数据
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI: 10.1016/S1556-0864(25)00237-0
C.C. Schumann , D.M. Behringer , J.B. Kuon , P. Sadjadian , W. Blau , A. Hassler , S. Wilop , M.K. Welslau , C. Ziske , D. Flieger , S. Kreher , M. Groschek , G. Hübner , A. Althoff , I. Dittrich , M. Link , T. Bluhmki , D. Waldenberger , S. Gütz , E. von der Heyde
{"title":"42P: First-line (1L) nivolumab (N) + ipilimumab (I) with 2 cycles of platinum-based chemotherapy (C) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): Interim data from the German non-interventional study (NIS) FINN","authors":"C.C. Schumann , D.M. Behringer , J.B. Kuon , P. Sadjadian , W. Blau , A. Hassler , S. Wilop , M.K. Welslau , C. Ziske , D. Flieger , S. Kreher , M. Groschek , G. Hübner , A. Althoff , I. Dittrich , M. Link , T. Bluhmki , D. Waldenberger , S. Gütz , E. von der Heyde","doi":"10.1016/S1556-0864(25)00237-0","DOIUrl":"10.1016/S1556-0864(25)00237-0","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Pages S37-S38"},"PeriodicalIF":21.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143725719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
European Lung Cancer Congress (ELCC) 2025 Officers 欧洲肺癌大会(ELCC) 2025官员
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI: 10.1016/S1556-0864(25)00192-3
{"title":"European Lung Cancer Congress (ELCC) 2025 Officers","authors":"","doi":"10.1016/S1556-0864(25)00192-3","DOIUrl":"10.1016/S1556-0864(25)00192-3","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Page xiv"},"PeriodicalIF":21.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143725877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
14P: Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase II trial 14P:巩固立体定向放疗治疗一线化疗免疫治疗后少残留非小细胞肺癌:单组,II期试验
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI: 10.1016/S1556-0864(25)00209-6
H. Chen , L. Yu , F. Liang , Y. Zhou , L. Chu , X. Chu , X. Yang , J. Zhang , Y. Pang , Z. Wang , Z. Yuan , J. Ni , Z. Zhu
{"title":"14P: Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase II trial","authors":"H. Chen , L. Yu , F. Liang , Y. Zhou , L. Chu , X. Chu , X. Yang , J. Zhang , Y. Pang , Z. Wang , Z. Yuan , J. Ni , Z. Zhu","doi":"10.1016/S1556-0864(25)00209-6","DOIUrl":"10.1016/S1556-0864(25)00209-6","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Page S18"},"PeriodicalIF":21.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143725959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LBA1: First-line (1L) fulzerasib + cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study LBA1:一线(1L) fulzerasib + cetuximab治疗KRAS G12Cm晚期NSCLC:来自KROCUS研究的最新疗效和安全性
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2025-03-01 DOI: 10.1016/S1556-0864(25)00194-7
M. Majem , V. Gregorc , G. Lo Russo , M. Maio , S. Salvagni , V. Gutierrez Calderon , M. Gonzalez Cao , S. Sandiego Contreras , A. Koumarianou , A. Bearz , R. Bernabe Caro , S. Viteri , M.F. Sanmamed , F. Zagouri , M.T. Moran Bueno , Y. Zhang , Y. Shan , H. Zhu , R. Rosell
{"title":"LBA1: First-line (1L) fulzerasib + cetuximab in KRAS G12Cm advanced NSCLC: Updated efficacy and safety from KROCUS study","authors":"M. Majem , V. Gregorc , G. Lo Russo , M. Maio , S. Salvagni , V. Gutierrez Calderon , M. Gonzalez Cao , S. Sandiego Contreras , A. Koumarianou , A. Bearz , R. Bernabe Caro , S. Viteri , M.F. Sanmamed , F. Zagouri , M.T. Moran Bueno , Y. Zhang , Y. Shan , H. Zhu , R. Rosell","doi":"10.1016/S1556-0864(25)00194-7","DOIUrl":"10.1016/S1556-0864(25)00194-7","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Page S1"},"PeriodicalIF":21.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143725975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信